https://clinicaltrials.gov/ct2/show/NCT03941132?type=Intr&cond=type+1+diabetes&phase=01234&lup_d=14&lupd_s=02%2F10%2F2019&lupd_e=05%2F29%2F2019&sort=nwst
STUDY TITLE:
Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
DESCRIPTION:
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Ustekinumab; Drug: Placebo
Sponsors: University of British Columbia; Juvenile Diabetes Research Foundation; Janssen, LP
Not yet recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03941132
FIRST POSTED:
Tue, 07 May 2019 12:00:00 EDT
LAST UPDATE POSTED:
May 7, 2019
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03941132?type=Intr&cond=type+1+diabetes&phase=01234&lup_d=14&lupd_s=02%2F10%2F2019&lupd_e=05%2F29%2F2019&sort=nwst
